Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6P3Q

Calpain-5 (CAPN5) Protease Core (PC)

Summary for 6P3Q
Entry DOI10.2210/pdb6p3q/pdb
DescriptorCalpain-5 (1 entity in total)
Functional Keywordscystein protease, peptide binding protein, calcium binding protein, protease domain, hydrolase
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight82733.20
Authors
Velez, G.,Sun, Y.J.,Khan, S.,Yang, J.,Koster, H.J.,Lokesh, G.,Mahajan, V. (deposition date: 2019-05-24, release date: 2020-02-05, Last modification date: 2024-04-03)
Primary citationVelez, G.,Sun, Y.J.,Khan, S.,Yang, J.,Herrmann, J.,Chemudupati, T.,MacLaren, R.E.,Gakhar, L.,Wakatsuki, S.,Bassuk, A.G.,Mahajan, V.B.
Structural Insights into the Unique Activation Mechanisms of a Non-classical Calpain and Its Disease-Causing Variants.
Cell Rep, 30:881-892.e5, 2020
Cited by
PubMed Abstract: Increased calpain activity is linked to neuroinflammation including a heritable retinal disease caused by hyper-activating mutations in the calcium-activated calpain-5 (CAPN5) protease. Although structures for classical calpains are known, the structure of CAPN5, a non-classical calpain, remains undetermined. Here we report the 2.8 Å crystal structure of the human CAPN5 protease core (CAPN5-PC). Compared to classical calpains, CAPN5-PC requires high calcium concentrations for maximal activity. Structure-based phylogenetic analysis and multiple sequence alignment reveal that CAPN5-PC contains three elongated flexible loops compared to its classical counterparts. The presence of a disease-causing mutation (c.799G>A, p.Gly267Ser) on the unique PC2L2 loop reveals a function in this region for regulating enzymatic activity. This mechanism could be transferred to distant calpains, using synthetic calpain hybrids, suggesting an evolutionary mechanism for fine-tuning calpain function by modifying flexible loops. Further, the open (inactive) conformation of CAPN5-PC provides structural insight into CAPN5-specific residues that can guide inhibitor design.
PubMed: 31968260
DOI: 10.1016/j.celrep.2019.12.077
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.8 Å)
Structure validation

226707

건을2024-10-30부터공개중

PDB statisticsPDBj update infoContact PDBjnumon